AIM2 and atherosclerosis: Finally, the authors concluded that AIM2 promotes the activity the N-terminal domain of GSDMD (GSDMD-N), which is required for pyroptosis (43), thereby accelerating pyroptosis in VSMC and unmasking AIM2 as an active participant in atherosclerosis.